sulfaphenazole has been researched along with Cyanosis in 1 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| THAL, W | 1 |
| WERNER, U | 1 |
1 other study available for sulfaphenazole and Cyanosis
| Article | Year |
|---|---|
[METHEMOGLOBINEMIAS OF YOUNG INFANTS DUE TO SULFAMETHOXYPYRIDAZINE].
Topics: Bronchitis; Cyanosis; Dyspepsia; Infant; Infant, Newborn; Meningitis; Methemoglobinemia; Sulfamethox | 1964 |